Retroactive_airdrop
vip
Age 9.9 Yıl
Peak Tier 1
No content yet
## Why Smart Investors Ignore Market Cap and Use Enterprise Value Instead
When evaluating whether a company is truly expensive or cheap, most retail investors make a critical mistake: they only look at market capitalization. They miss the full picture. Enterprise value (EV) is the metric that reveals what you're *actually* paying for a business, just like knowing the true cost of that used car after accounting for the cash you found in the trunk.
Think of it this way: if you acquire a company with $10 billion market cap but it carries $5 billion in debt you must assume, plus $1 billion in cash
  • Reward
  • Comment
  • Repost
  • Share
Tech Stocks Ignite Broad Market Rally, Sentiment Turns Constructive
Friday's trading session showcased strong momentum across equities as technology and semiconductor stocks led a vigorous advance. Market sentiment turned decisively positive, with the S&P 500 gaining +0.88% and the Nasdaq 100 surging +1.28%, while the Dow Jones closed up +0.38%.
BTC1.35%
Expand All
  • Reward
  • Comment
  • Repost
  • Share
The Cryptographic Pioneer: A Decade Remembering Hal Finney's Enduring Impact on Bitcoin
A full ten years have passed since Hal Finney, the legendary cryptographer whose early vision shaped Bitcoin's foundation, bid farewell to the world. The visionary computer scientist left behind a legacy that continues to reverberate through the cryptocurrency ecosystem. Finney's battle with ALS, wh
BTC1.35%
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Natural Gas Storage Draw Triggers Price Surge Amid Cold Weather Outlook
January Nymex natural gas futures gained momentum on Wednesday, closing +0.077 (+1.72%), propelled by a sharper-than-expected inventory decline. The EIA's weekly report showed natural gas storage contracted by 11 bcf for the week ending November 21, exceeding market consensus of 9 bcf and
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Stora Enso Unveils Ambitious 2026 Business Restructuring: New Four-Segment Model Takes Center Stage
Stora Enso plans a significant operational transformation starting in 2026, consolidating its financial reporting structure from six to four segments to enhance strategic focus and accountability. The company aims for a 10% EBIT margin and over 4% annual revenue growth, with a commitment to shareholder payouts exceeding 50%.
ai-iconThe abstract is generated by AI
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Spectrum IQ Smart Pumps Achieve Major Breakthrough in Hospital Safety: Real-World Clinical Data Reveals Significant Improvements
A groundbreaking clinical analysis involving over 1.3 million intravenous infusions has demonstrated how BAX's connected infusion technology can fundamentally transform patient safety and nursing efficiency in hospital settings. The study, presented at the American Society of Health-System
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Why IonQ's Trapped-Ion Breakthrough Could Reshape the Quantum Computing Landscape
The Technology That Sets It Apart
In the quantum realm, IonQ stands apart from mainstream competitors by adopting the trapped-ion approach—a fundamentally different path compared to the superconducting methods most industry players favor. While larger tech companies pursue superconducting quantum
Expand All
  • Reward
  • Comment
  • Repost
  • Share
## How a 19-Year-Old Built a $150 Million Fortune Through Crypto Ventures: The Barron Trump Story
When discussing the Trump family's financial empire, most attention focuses on President Donald Trump's $6 billion net worth accumulated through real estate, entertainment, and his merger with Trump Media & Technology Group. Yet his youngest son, Barron Trump, has quietly constructed a substantial personal wealth portfolio estimated at $150 million—largely through the emerging cryptocurrency sector. The question isn't just how, but what this reveals about wealth-building opportunities in digital a
WLFI4.59%
USD1-0.01%
TOKEN-1.08%
  • Reward
  • Comment
  • Repost
  • Share
Everything New Dog Parents Need To Know About Protective Immunizations
Welcoming a new puppy into your home brings joy and responsibility—and one of those critical responsibilities is ensuring your pup stays protected from serious diseases. Understanding the right vaccine regimen from the start sets the foundation for your dog's long-term health. Let's explore what
Expand All
  • Reward
  • Comment
  • Repost
  • Share
What Market Watchers Believe About AtriCure Stock: A 36.3% Upside in Focus?
AtriCure (ATRC) shares have climbed 3.5% over the last four weeks, settling at $37.74 in recent trading. Yet according to what Wall Street analysts believe could happen next, the potential appreciation may be far from over. The consensus price target sits at $51.44—suggesting a possible 36.3% gain f
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Meta's New Link Monetize Strategy: Charging Users For Content Distribution
Meta is launching usage limits on link sharing for select users, requiring a subscription for additional links. This shift aims to monetize previously free features, impacting creators and small businesses reliant on organic reach and audience growth.
ai-iconThe abstract is generated by AI
Expand All
  • Reward
  • Comment
  • Repost
  • Share
How Netflix's $72B Warner Bros. Gambit Could Blow Open the Streaming Competition—And Which ETFs Win
The entertainment industry just experienced a seismic shift. Netflix has secured control of Warner Bros. Discovery's studio and streaming assets in a blockbuster $72 billion equity transaction—valued at $82.7 billion including debt—that reshapes the entire streaming landscape. This acquisition
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Regeneron's EYLEA HD Clears FDA With Monthly Dosing Flexibility—What It Means For RVO Market
Regeneron Pharmaceuticals (REGN) has achieved a significant regulatory milestone with FDA clearance of EYLEA HD for macular edema secondary to retinal vein occlusion, while simultaneously expanding flexible dosing options across its entire EYLEA portfolio. This dual approval signals a strategic
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Understanding Next of Kin: Why It Matters for Your Estate and Inheritance
The Critical Role Next of Kin Plays in Your Future
When life takes an unexpected turn, someone needs to step in and make decisions on your behalf—whether that's managing your finances, approving medical treatment, or handling your estate. This is where next of kin becomes essential. Unlike
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Ethereum's Sharp Decline: Institutional Capital Flight and Liquidation Cascade
The Perfect Storm Behind Today's Plunging Prices
Ethereum (ETH) has been taking a beating in recent market sessions, with the second-largest cryptocurrency by market cap experiencing notable downward pressure. Current trading shows ETH at $2.96K with a 24-hour change of +0.61%, though intraday
ETH0.91%
BTC1.35%
XRP-0.26%
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Cyprium Metals Greenlights Major Restart Initiative: Nifty Cathode Output Targeted for Mid-2026
Cyprium Metals Limited has received authorization for its Nifty Copper Complex restart strategy, aiming for copper cathode production by mid-2026. The plan includes re-leaching existing materials and refurbishing the SXEW plant, supporting future production growth and operational longevity.
ai-iconThe abstract is generated by AI
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Why Regeneron Could Be the Best Stock to Buy Tomorrow—Here's What You Need to Know
The Setup: A Biotech Giant Fighting Back
Regeneron Pharmaceuticals [(NASDAQ: REGN)](/market-activity/stocks/regn) has taken its lumps over the past 18 months, but here's the thing—the pressure is easing, and the company is setting itself up for a meaningful comeback. Two major catalysts suggest th
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Protalix BioTherapeutics Stock Gains on Secarna Partnership for Rare Kidney Disease Treatments
Biotech collaboration moves forward with AI-powered therapy development
Protalix BioTherapeutics, Inc. (PLX) shares climbed 2.78% to $1.85 in pre-market trading Wednesday, following the disclosure of a strategic partnership with Secarna Pharmaceuticals, a German biopharmaceutical innovator. The two companies have joined forces to create advanced antisense oligonucleotide (ASO) therapies targeting rare kidney conditions.
**The Strategic Alliance & Technology Focus**
Under the agreement structure, Prot
  • Reward
  • Comment
  • Repost
  • Share
Cotton Markets Climb Wednesday Morning After Tuesday Selloff
Cotton futures rebounded Wednesday, recovering 39 to 48 points after a sharp decline on Tuesday due to weak commodity markets and a stronger dollar. Traders are watching for stabilization amidst mixed market signals and ongoing pressures from global valuations.
ai-iconThe abstract is generated by AI
Expand All
  • Reward
  • Comment
  • Repost
  • Share
Building Long-Term Wealth Through Healthcare Sector Investments: A Guide for New Market Participants
Understanding the Stock Market for Beginners in Healthcare Investing
For those beginning to understand the stock market for beginners, the healthcare sector offers compelling opportunities if you maintain a patient, decade-long investment perspective. The challenge isn't finding healthcare
Expand All
  • Reward
  • Comment
  • Repost
  • Share
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)